US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 0.908
- +0.083+10.06%
Close Sep 6 16:00 ET
- 0.900
- -0.008-0.87%
Post 19:59 ET
62.11MMarket Cap-524P/E (TTM)
1.160High0.870Low21.34MVolume0.959Open0.825Pre Close21.44MTurnover66.58%Turnover RatioLossP/E (Static)68.40MShares3.14052wk High0.63P/B29.10MFloat Cap0.70052wk Low--Dividend TTM32.05MShs Float63.620Historical High--Div YieldTTM35.15%Amplitude0.700Historical Low1.004Avg Price1Lot Size
Vor Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.76%29.04M | 6.26%32.33M | 34.92%126.04M | 13.75%28.12M | 46.53%35.32M | 47.64%32.17M | 33.43%30.42M | 35.35%93.42M | 35.07%24.73M | 29.56%24.1M |
| Selling and administrative expenses | -12.87%7.21M | -5.91%8M | 9.88%31.72M | -5.69%7.23M | 6.70%7.71M | 28.15%8.28M | 13.13%8.51M | 34.34%28.87M | 36.52%7.66M | 27.29%7.23M |
| -General and administrative expense | -12.87%7.21M | -5.91%8M | 9.88%31.72M | -5.69%7.23M | 6.70%7.71M | 28.15%8.28M | 13.13%8.51M | 34.34%28.87M | 36.52%7.66M | 27.29%7.23M |
| Research and development costs | -8.68%21.82M | 10.98%24.32M | 46.11%94.32M | 22.48%20.9M | 63.59%27.61M | 55.85%23.9M | 43.42%21.92M | 35.81%64.55M | 34.42%17.06M | 30.56%16.88M |
| Operating profit | 9.76%-29.04M | -6.26%-32.33M | -34.92%-126.04M | -13.75%-28.12M | -46.53%-35.32M | -47.64%-32.17M | -33.43%-30.42M | -35.35%-93.42M | -35.07%-24.73M | -29.56%-24.1M |
| Net non-operating interest income expense | -45.51%1.2M | -23.48%1.52M | 517.30%8.17M | 128.59%1.86M | 579.23%2.13M | 1,550.38%2.2M | 3,057.14%1.99M | 1,012.61%1.32M | 1,409.26%815K | 552.08%313K |
| Non-operating interest income | -45.51%1.2M | -23.48%1.52M | 517.30%8.17M | 128.59%1.86M | 579.23%2.13M | 1,550.38%2.2M | 3,057.14%1.99M | 1,012.61%1.32M | 1,409.26%815K | 552.08%313K |
| Other net income (expense) | ||||||||||
| Income before tax | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -33.67%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Income tax | ||||||||||
| Net income | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -33.67%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Net income continuous Operations | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -33.67%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -33.67%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -31.32%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Basic earnings per share | 8.89%-0.41 | -4.65%-0.45 | 24.89%-1.75 | 26.92%-0.38 | 22.22%-0.49 | 22.41%-0.45 | 29.51%-0.43 | -10.95%-2.33 | -8.33%-0.52 | -26.00%-0.63 |
| Diluted earnings per share | 8.89%-0.41 | -4.65%-0.45 | 24.89%-1.75 | 26.92%-0.38 | 22.22%-0.49 | 22.41%-0.45 | 29.51%-0.43 | -10.95%-2.33 | -8.33%-0.52 | -26.00%-0.63 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
